CN1223886A - Pathogenic factor eliminating and healthy energy supporting anticancer medicine - Google Patents

Pathogenic factor eliminating and healthy energy supporting anticancer medicine Download PDF

Info

Publication number
CN1223886A
CN1223886A CN 98124890 CN98124890A CN1223886A CN 1223886 A CN1223886 A CN 1223886A CN 98124890 CN98124890 CN 98124890 CN 98124890 A CN98124890 A CN 98124890A CN 1223886 A CN1223886 A CN 1223886A
Authority
CN
China
Prior art keywords
medicine
radix
ring side
herba
requested
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 98124890
Other languages
Chinese (zh)
Other versions
CN1082376C (en
Inventor
孙景华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN98124890A priority Critical patent/CN1082376C/en
Publication of CN1223886A publication Critical patent/CN1223886A/en
Application granted granted Critical
Publication of CN1082376C publication Critical patent/CN1082376C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

An anticancer medicine includes two components: capsule prepared from 12 Chinese-medicinal materials such as pubescent holly root, barbat skullcap, etc and oral liquid prepared from 19 Chinese-medicinal materials such as pseudostellaria root, White atractylodes rhizome, etc. Its preparing steps include crushing raw materials, decoction, concentrating, drying, sieving and mingling. Its advantages are distinct curative effect and convenient application.

Description

A kind of PTS with the two-way therapeutical effect of eliminating pathogenic factor for supporting vital QI
The present invention relates to treat the medicine of cancer, exactly is a kind of PTS with the two-way therapeutical effect of eliminating pathogenic factor for supporting vital QI, and belonging to the Chinese herbal medicine is the Chinese patent medicine of feedstock production.
In the last few years, Chinese medicine is to the treatment for cancer effect, admitted by people day by day, the research of the anticancer middle hospital of medicine and pharmacology bound pair medicine is more both at home and abroad, but all adopt single side's pharmaceutically dosage form, single execute control general plan (controlling or treating different diseases with the same therapeutic principle) as different disease is different, the single therapy effect (act as the master with single therapy, promptly main eliminating evil or mainly set upright) mode, so often when treatment of cancer, need take into account eliminating evil, attend to one thing and lose sight of another aspect setting upright two, can't obtain desirable therapeutic.
Purpose of the present invention is intended to disclose a kind of PTS with the two-way therapeutical effect of eliminating pathogenic factor for supporting vital QI, and it is eliminating evil and set upright the problem of attending to one thing and lose sight of another aspect two in treatment of cancer to have solved conventional Chinese medicine.
To achieve the object of the present invention, concrete solution is based on Chinese medicine to pathogenesis of cancer mechanism and Therapeutic Principle, in eliminating pathogenic factor for supporting vital QI Chinese medicine, refine top grade, the screening elite, the science compatibility, rigorous prescription, providing a kind of is eliminating evilly to set upright again, two cover side's medicine capacities, intersection, use in conjunction, the square medicine of dispelled to reach evil-driving and cooling method, resolving therapy, empty body and function reinforcement and method being held up.Concrete component following (by weight than):
One ring side's medicine composition:
Radix Ilicis Pubescentis 15-25 Herba Scutellariae Barbatae 6-12 Herba Selaginellae Doederleinii 4-10 Herba Hedyotidis Diffusae 4-10
Fructus Aurantii Immaturus 4-10 moxibustion Rhizoma Pinelliae 4-10 Radix Salviae Miltiorrhizae 6-12 Flos Carthami 6-12
Rhizoma Curcumae 4-10 Rhizoma Curcumae Longae 4-10 Rhizoma Corydalis 4-10 Pericarpium Papaveris 2-8
Bicyclo-side's medicine composition:
Radix Pseudostellariae 10-20 Rhizoma Atractylodis Macrocephalae 4-10 Poria 4-10 Radix Glycyrrhizae 2-8
Radix Rehmanniae 3-7 Flos Hibisci Mutabilis 4-10 Aspongopus 4-10 Arillus Longan 4-10
Herba Cistanches 4-10 Colla cornus cervi 3-7 Hericium erinaceus (Bull. Ex Fr.) Pers. 3-7 Tremella 3-7
Stichopus japonicus 4-10 Radix Glehniae 3-7 Bulbus Lilii 3-7 Seem Lablab Album 3-7
Fructus Ligustri Lucidi 4-10 Herba Epimedii 4-10%
In ring side's medicine composition,, add different flavor medicines at various cancers according to theory of Chinese medical science determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs principle:
Cerebroma:
Rhizoma Acori Graminei 30-40 Fructus Psoraleae 20-30 Bombyx Batryticatus 20-30 Scolopendra 10-20;
Nasopharyngeal carcinoma, laryngeal carcinoma, carcinoma of maxillary sinus:
Radix Sophorae Tonkinensis 20-30 Fructus Arctii 30-50 Rhizoma Belamcandae 20-30 Fructus Chebulae 15-25;
Thyroid carcinoma, breast carcinoma, malignant lymphoma, skin carcinoma:
Fructus Aristolochiae 30-40 Radix Sophorae Flavescentis 20-30 Sargassum 30-40 Thallus Laminariae (Thallus Eckloniae) 20-30;
Pulmonary carcinoma, mediastinum tumor, mesothelioma of pleura:
Radix Scutellariae 25-40 Bulbus Fritillariae Thunbergii 25-40 Semen Armeniacae Amarum 20-30 Indigo Naturalis 20-30;
The esophageal carcinoma, carcinoma of gastric cardia:
Rabdosia rubescens 20-40 Herba Patriniae 15-30 Fructus Sophorae 20-40 Fructus Polygoni Orientalis 20-40;
Gastric cancer, intestinal cancer:
Herba Solani Nigri 15-30 Cortex Magnoliae Officinalis 30-50 Pseudobulbus Cremastrae Seu Pleiones 15-30 Herba Sarcandrae 15-30;
Hepatocarcinoma, cancer of pancreas, carcinoma of gallbladder, cancer of biliary duct:
Herba Artemisiae Scopariae 30-40 Radix Gentianae 20-30 Lignum Sappan 20-30 Fructus Trichosanthis 20-30;
Renal carcinoma, bladder cancer, carcinoma of prostate:
Polyporus 30-40 Radix Stephaniae Tetrandrae 20-30 Caulis Akebiae 15-25 Herba Lobeliae Chinensis 20-30;
Cervical cancer, carcinoma of uterine body, ovarian cancer, choriocarcinoma:
Pseudobulbus Bletillae (Rhizoma Bletillae) 20-30 Folium Artemisiae Argyi 20-30 Radix Trichosanthis 30-40 Herba Agrimoniae 30-40;
Osteosarcoma, metastatic bone cancer, soft tissue sarcoma, the plain tumor of black-envelope:
Nidus Vespae 20-30 Eupolyphaga Seu Steleophaga 15-25 Radix Et Caulis Acanthopanacis Senticosi 20-30 Radix Phytolaccae 20-30;
Leukemia:
Radix Arnebiae (Radix Lithospermi) 30-50 Cornu Saigae Tataricae 10-15 Folium Isatidis 20-30 Radix Isatidis 20-30.
Concrete production is as follows:
One ring side's medicine with described all medicines respectively according to a conventional method drying and crushing put into 5 times of water, heating is boiled and is carried 3 hours, leaches the medicinal liquid deposit, adds 5 times of water gagings again, boils and carries 2 hours, it is standby to leach medicinal liquid, adds 5 times of water gagings for the third time again, boils and carries 1 hour, leaches medicinal liquid again; Merge to boil for three times and carry medicinal liquid, be condensed into thick paste, put into the drying baker drying, pulverize, cross 100 mesh sieves and get smart powder, fill glue is assisted, and every is 0.3g, is equivalent to crude drug 1.75g.
For bicyclo-side's medicine above-mentioned all medicines are pressed the Chinese medicine processing rules respectively and concoct processing, by the prescription kind, the accurate one by one weighing preparation raw material of weight is put into the interlayer steam pot, adds quintuple water, and heating is boiled and carried 3 hours (calculating with the water boiling), and it is standby to leach medicinal liquid; Carry 2 hours with adding quintuple water in the pot, boiling again, it is standby to leach medicinal liquid; Add 5 times of water gagings for the third time again, boil and carry 1 hour, leach medicinal liquid.Merge three times medicinal liquid, filter clarification repeatedly; The filtrate heating is concentrated into the clear paste that relative density is 1.05-1.10.Add the Mel, the sorbic acid first that make, add ionized water again to full dose, make oral liquid, every 10ml includes crude drug 3.0g.
Effect of the present invention is: used the inventor confirms to have fine antitumaous effect through practice Radix Ilicis Pubescentis in ring side's medicine except that prior art has been used for the Chinese medicine of treatment of cancer, Fructus Aurantii Immaturus, Rhizoma Corydalis, Pericarpium Papaveris, be monarch with the Radix Ilicis Pubescentis in the prescription, blood circulation promoting and blood stasis dispelling, open long-pendingization knot, anti-cancer and inhibiting tumor Zhi Qiben, the pathogenic fire reducing detoxifcation, dispelling phlegm and alleviating pain is cured its mark, and can be lastingly blood vessel dilating forcefully, blood circulation promoting, microcirculation improvement, thereby prevent that host's cancerigenic factor is detained also to the initial sum of the tumor origin cause of formation multistage theory startup stage and therefore form cancer and have important function.In bicyclo-side's medicine except that prior art is used for cancer raise immunity person, enhancing immunity curative effect outstanding Radix Pseudostellariae, Flos Hibisci Mutabilis, Arillus Longan, Aspongopus, Herba Cistanches, Colla cornus cervi have also been proposed to set upright, particularly Radix Pseudostellariae has good enhancing immunity effect through experiment and this medicine of clinical research confirmation in prescription, but activating macrophage performance phagocytosis induces body to produce interferon and interleukin.
One ring side's medicine and bicyclo-side's medicine are two links of the present invention, and be all linked with one another, complements each other; Drug combination is executed orientation, Zhiduo County, the medication great dynamics; Seriality is strong, and human body and focus constantly are under the drug effect, and the medicine active ingredient constantly acts on therapeutic goal.Through clinical observation, the present invention is 85.3% to the total effective rate of various treatments of cancer, and can obviously alleviate middle and advanced stage patient misery, improves symptom, improves life quality, prolongs the existence time limit, and the clinical remission rate reaches 95%.

Claims (12)

1, a kind of PTS with the two-way therapeutical effect of eliminating pathogenic factor for supporting vital QI is characterized in that: be made of ring side's medicine and bicyclo-side's medicine, it is as follows specifically to fill a prescription:
A, ring side's medicine by weight than:
Radix Ilicis Pubescentis 15-25 Herba Scutellariae Barbatae 6-12 Herba Selaginellae Doederleinii 4-10 Herba Hedyotidis Diffusae 4-10
Fructus Aurantii Immaturus 4-10 moxibustion Rhizoma Pinelliae 4-10 Radix Salviae Miltiorrhizae 6-12 Flos Carthami 6-12
Rhizoma Curcumae 4-10 Rhizoma Curcumae Longae 4-10 Rhizoma Corydalis 4-10 Pericarpium Papaveris 2-8;
B, bicyclo-side's medicine by weight than:
Radix Pseudostellariae 10-20 Rhizoma Atractylodis Macrocephalae 4-1 Poria 4-10 Radix Glycyrrhizae 2-8 Radix Rehmanniae 3-7 Flos Hibisci Mutabilis 4-10
Aspongopus 4-10 Arillus Longan 4-10 Herba Cistanches 4-10 Colla cornus cervi 3-7 Hericium erinaceus (Bull. Ex Fr.) Pers. 3-7 Tremella 3-7
Stichopus japonicus 4-10 Radix Glehniae 3-7 Bulbus Lilii 3-7 Seem Lablab Album 3-7 Fructus Ligustri Lucidi 4-10 Herba Epimedii 4-10.
2,1 described PTS as requested is characterized in that: also have following medicine in ring side's medicine:
Rhizoma Acori Graminei 30-40 Fructus Psoraleae 20-30 Bombyx Batryticatus 20-30 Scolopendra 10-20.
3,1 described PTS as requested is characterized in that: also comprise in ring side's medicine:
Radix Sophorae Tonkinensis 20-30 Fructus Arctii 30-50 Rhizoma Belamcandae 20-30 Fructus Chebulae 15-25.
4,1 described PTS as requested is characterized in that: also have following medicine in ring side's medicine:
Fructus Aristolochiae 30-40 Radix Sophorae Flavescentis 20-30 Sargassum 30-40 Thallus Laminariae (Thallus Eckloniae) 20-30.
5,1 described PTS as requested is characterized in that: also have following medicine in ring side's medicine:
Radix Scutellariae 25-40 Bulbus Fritillariae Thunbergii 25-40 Semen Armeniacae Amarum 20-30 Indigo Naturalis 20-30.
6,1 described PTS as requested is characterized in that: also have following medicine in ring side's medicine:
Rabdosia rubescens 20-40 Herba Patriniae 15-30 Fructus Sophorae 20-40 Fructus Polygoni Orientalis 20-40.
7,1 described PTS as requested is characterized in that: also have following medicine in ring side's medicine:
Herba Solani Nigri 15-30 Cortex Magnoliae Officinalis 30-50 Pseudobulbus Cremastrae Seu Pleiones 15-30 Herba Sarcandrae 15-30.
8,1 described PTS as requested is characterized in that: also have following medicine in ring side's medicine:
Herba Artemisiae Scopariae 30-40 Radix Gentianae 20-30 Lignum Sappan 20-30 Fructus Trichosanthis 20-30.
9,1 described PTS as requested is characterized in that: also have following medicine in ring side's medicine:
Polyporus 30-40 Radix Stephaniae Tetrandrae 20-30 Caulis Akebiae 15-25 Herba Lobeliae Chinensis 20-30.
10,1 described PTS as requested is characterized in that: also have following medicine in ring side's medicine:
Pseudobulbus Bletillae (Rhizoma Bletillae) 20-30 Folium Artemisiae Argyi 20-30 Radix Trichosanthis 30-40 Herba Agrimoniae 30-40.
11,1 described PTS as requested is characterized in that: also have following medicine in ring side's medicine:
Nidus Vespae 20-30 Eupolyphaga Seu Steleophaga 15-25 Radix Et Caulis Acanthopanacis Senticosi 20-30 Radix Phytolaccae 20-30.
12,1 described PTS as requested is characterized in that: also have following medicine in ring side's medicine:
Radix Arnebiae (Radix Lithospermi) 30-50 Cornu Saigae Tataricae 10-15 Folium Isatidis 20-30 Radix Isatidis 20-30.
CN98124890A 1998-12-03 1998-12-03 Pathogenic factor eliminating and healthy energy supporting anticancer medicine Expired - Fee Related CN1082376C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN98124890A CN1082376C (en) 1998-12-03 1998-12-03 Pathogenic factor eliminating and healthy energy supporting anticancer medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98124890A CN1082376C (en) 1998-12-03 1998-12-03 Pathogenic factor eliminating and healthy energy supporting anticancer medicine

Publications (2)

Publication Number Publication Date
CN1223886A true CN1223886A (en) 1999-07-28
CN1082376C CN1082376C (en) 2002-04-10

Family

ID=5228883

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98124890A Expired - Fee Related CN1082376C (en) 1998-12-03 1998-12-03 Pathogenic factor eliminating and healthy energy supporting anticancer medicine

Country Status (1)

Country Link
CN (1) CN1082376C (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1331502C (en) * 2005-10-24 2007-08-15 袁莉 Chinese medicine composition
CN101670056B (en) * 2008-09-10 2011-08-03 吴昆仑 Medicament for treating malignant tumor
CN103933188A (en) * 2014-04-15 2014-07-23 王贵林 Traditional Chinese medicine composition for inhibiting tumor cell proliferation, preparation method and use
CN103933378A (en) * 2014-03-19 2014-07-23 陈鲁青 Traditional Chinese medicine preparation for treatment of ovarian tumor and preparation method thereof
CN105012888A (en) * 2015-08-13 2015-11-04 李荣勤 Composition for treating carcinoma of uterine cervix and preparing method
CN105194271A (en) * 2015-11-06 2015-12-30 青岛麦瑞特医药技术有限公司 Traditional Chinese medicine preparation for treating advanced breast cancer by virtue of combined chemotherapy
CN105233173A (en) * 2015-11-11 2016-01-13 梁占强 Composition for treating tumors of livers, gall and pancreas and preparation method thereof
CN114632117A (en) * 2022-03-23 2022-06-17 统合生命健康科技(金华)有限公司 Traditional Chinese medicine composition for treating gastric cancer, cholangiocarcinoma or liver cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1047975A (en) * 1989-06-13 1990-12-26 李晨芙 A kind of compound method of anticancer agent
CN1078146A (en) * 1992-05-08 1993-11-10 朱海涛 A kind of high-efficiency broad spectrum is controlled the preparation method of cancer Chinese herbal medicine

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1331502C (en) * 2005-10-24 2007-08-15 袁莉 Chinese medicine composition
CN101670056B (en) * 2008-09-10 2011-08-03 吴昆仑 Medicament for treating malignant tumor
CN103933378A (en) * 2014-03-19 2014-07-23 陈鲁青 Traditional Chinese medicine preparation for treatment of ovarian tumor and preparation method thereof
CN103933188A (en) * 2014-04-15 2014-07-23 王贵林 Traditional Chinese medicine composition for inhibiting tumor cell proliferation, preparation method and use
CN103933188B (en) * 2014-04-15 2015-07-08 王贵林 Traditional Chinese medicine composition for inhibiting tumor cell proliferation, preparation method and use
CN105012888A (en) * 2015-08-13 2015-11-04 李荣勤 Composition for treating carcinoma of uterine cervix and preparing method
CN105194271A (en) * 2015-11-06 2015-12-30 青岛麦瑞特医药技术有限公司 Traditional Chinese medicine preparation for treating advanced breast cancer by virtue of combined chemotherapy
CN105233173A (en) * 2015-11-11 2016-01-13 梁占强 Composition for treating tumors of livers, gall and pancreas and preparation method thereof
CN114632117A (en) * 2022-03-23 2022-06-17 统合生命健康科技(金华)有限公司 Traditional Chinese medicine composition for treating gastric cancer, cholangiocarcinoma or liver cancer

Also Published As

Publication number Publication date
CN1082376C (en) 2002-04-10

Similar Documents

Publication Publication Date Title
CN1169541C (en) Medicine for treating rheumatoid arthritis
CN1354014A (en) Gongbu ointment
CN1485083A (en) Capsule for thyroid cancer / tumor and lymph node
CN1286490C (en) anti inflammation decoction for treating morbid leucorrhea, etc.
CN1082376C (en) Pathogenic factor eliminating and healthy energy supporting anticancer medicine
CN1167452C (en) Medicine for curing AIDS
CN101366903B (en) Traditional Chinese medicine composition for treating climacteric syndrome
CN102657736B (en) Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition
CN1686500A (en) Chinese medicinal preparation for treating breast impediment
CN1698735A (en) Medicine for treating psoriasis
CN1049827C (en) Anti-cancer powder
CN1060391C (en) Traditional Chinese medicine for treating gynecological tumour
CN101167932A (en) Traditional Chinese medicine for treating chronic hepatitis B
CN1052889C (en) Chinese proprietary for curing hepatitis
CN1058165C (en) Chinese drugs for curing hepatitis B
CN1879783A (en) A medicine for treating diabetes
CN101979035A (en) Medicament for treating gynecological abnormal leucorrhea
CN1094057C (en) Liver ascites treating medicine
CN104873911A (en) Traditional Chinese medicine for oral administration for adjunctively treating sepsis
CN101450198A (en) Traditional Chinese medicine preparation mated with radiotherapy and chemotherapy
CN101181516B (en) Chinese medicine prescription orally taken for curing leukaemia
CN1814153A (en) Medicine composition for preventing and treating breast cancer and preparing method
CN1116050C (en) Medicine bolus for dredging meridian passage, nourishing blood and removing toxic material
CN1130529A (en) Aizikangfuning-Chinese patent drug for treating AIDS and preparing process thereof
CN1117581C (en) Chinese medicine for treating angina pectonis

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee